Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$12,342,187
+$1,734,765 QoQ
Shares Held
49,047
+0.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.08%
of 13F equity value
Holder Rank
#811
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONARCH CAPITAL MANAGEMENT INC holds $54,521,424 across 10 Drug Manufacturers - General names. ABBV ranks #3 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
119,322 | $15,332,877 | |
| 2 | JNJ |
Johnson & Johnson
|
57,752 | $14,667,275 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
49,047 | $12,342,187 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,685 | $5,140,142 | |
| 5 | PFE |
Pfizer Inc
|
127,572 | $3,071,933 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,815 | $1,372,220 | |
| 7 | LLY |
ELI LILLY & Co
|
1,108 | $1,328,968 | |
| 8 | NVO |
Novo Nordisk A S
|
16,150 | $774,231 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,342,187 | 49,047 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $10,607,422 | 48,772 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $11,331,276 | 49,592 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $11,686,749 | 50,474 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $9,535,670 | 51,372 | Shares | Sole | 2025-08-20 | |
| 2025-03-31 | $10,757,385 | 51,343 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $9,410,814 | 52,959 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $10,535,952 | 53,352 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $9,052,482 | 52,778 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $9,711,393 | 53,330 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $8,409,292 | 54,264 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $8,265,227 | 55,449 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $7,515,104 | 55,779 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $8,973,646 | 56,307 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $9,284,817 | 57,452 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $8,066,692 | 60,105 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $9,542,327 | 62,303 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $10,200,933 | 62,926 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $8,826,455 | 65,188 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $7,131,393 | 66,111 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $7,201,751 | 63,936 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $6,817,860 | 63,000 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $6,701,161 | 62,540 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $5,616,883 | 64,127 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $6,286,465 | 64,030 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $4,811,627 | 63,153 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||